| NCT03405376 |
Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03405376 |
Recruiting |
Yeungnam University College of Medicine |
2019-03-31 |
| NCT03396861 |
Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept |
https://ClinicalTrials.gov/show/NCT03396861 |
Recruiting |
Tufts Medical Center |
2020-05-31 |
| NCT03383328 |
Study for Optimizing Anti-inflammatory Prophylaxis |
https://ClinicalTrials.gov/show/NCT03383328 |
Completed |
Rigshospitalet, Denmark |
2019-12-18 |
| NCT03859245 |
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention |
https://ClinicalTrials.gov/show/NCT03859245 |
Recruiting |
Bristlecone Health, Inc. |
2020-09-30 |
| NCT03340610 |
IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab |
https://ClinicalTrials.gov/show/NCT03340610 |
Completed |
Southeast Retina Center, Georgia |
2018-12-31 |
| NCT03328715 |
iOCT for Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03328715 |
Recruiting |
Vienna Institute for Research in Ocular Surgery |
2020-09-01 |
| NCT03321513 |
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME |
https://ClinicalTrials.gov/show/NCT03321513 |
Active, not recruiting |
Jaeb Center for Health Research |
2021-12-20 |
| NCT03292796 |
RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery. |
https://ClinicalTrials.gov/show/NCT03292796 |
Active, not recruiting |
Norfolk and Norwich University Hospitals NHS Foundation Trust |
2019-12-31 |
| NCT03270865 |
Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging |
https://ClinicalTrials.gov/show/NCT03270865 |
Completed |
Notal Vision Ltd |
2018-02-01 |
| NCT03261635 |
Ranibizumab Plus Indomethacin |
https://ClinicalTrials.gov/show/NCT03261635 |
Completed |
Università degli Studi di Brescia |
2016-12-07 |
| NCT03246152 |
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA |
https://ClinicalTrials.gov/show/NCT03246152 |
Completed |
Cairo University |
2018-12-24 |
| NCT03226951 |
SDM Laser for Non Central Diabetic CSME |
https://ClinicalTrials.gov/show/NCT03226951 |
Completed |
Marashi Eye Clinic |
2018-01-31 |
| NCT03223714 |
Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03223714 |
Recruiting |
Chengdu Kanghong Biotech Co., Ltd. |
2019-12-31 |
| NCT03211741 |
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema |
https://ClinicalTrials.gov/show/NCT03211741 |
Recruiting |
University Hospital, Ghent |
2021-01-01 |
| NCT03197480 |
Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME |
https://ClinicalTrials.gov/show/NCT03197480 |
Recruiting |
Singapore National Eye Centre |
2020-12-31 |
| NCT03161652 |
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03161652 |
Recruiting |
Universidad Nacional Autonoma de Mexico |
2022-05-31 |
| NCT03143192 |
Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser |
https://ClinicalTrials.gov/show/NCT03143192 |
Completed |
Toronto Retina Institute |
2019-05-09 |
| NCT03126786 |
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03126786 |
Completed |
Clearside Biomedical, Inc. |
2018-04-17 |
| NCT03108352 |
Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03108352 |
Recruiting |
Chengdu Kanghong Biotech Co., Ltd. |
2019-12-31 |
| NCT03094819 |
PROTECT2: Diabetes Care - Eye Exam |
https://ClinicalTrials.gov/show/NCT03094819 |
Active, not recruiting |
Retinal Care Inc. |
2021-06-30 |
| NCT03093701 |
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03093701 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT03071068 |
A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03071068 |
Completed |
ThromboGenics |
2018-04-30 |
| NCT03056092 |
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab |
https://ClinicalTrials.gov/show/NCT03056092 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT03056079 |
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept |
https://ClinicalTrials.gov/show/NCT03056079 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT03038048 |
30g vs 33g Needle for Intravitreal Injections |
https://ClinicalTrials.gov/show/NCT03038048 |
Completed |
Wills Eye |
2017-04-27 |
| NCT03025945 |
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo |
https://ClinicalTrials.gov/show/NCT03025945 |
Completed |
Intuor Technologies, Inc. |
2017-01-31 |
| NCT02985619 |
Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02985619 |
Completed |
University of Sao Paulo |
2017-04-14 |
| NCT02953938 |
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety |
https://ClinicalTrials.gov/show/NCT02953938 |
Completed |
Novartis |
2018-12-28 |
| NCT02951351 |
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections |
https://ClinicalTrials.gov/show/NCT02951351 |
Completed |
Mayo Clinic |
2018-02-01 |
| NCT02949024 |
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02949024 |
Completed |
Clearside Biomedical, Inc. |
2017-04-12 |
| NCT02914613 |
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02914613 |
Completed |
SciFluor Life Sciences, Inc. |
2017-05-16 |
| NCT02867735 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema |
https://ClinicalTrials.gov/show/NCT02867735 |
Completed |
Novartis |
2018-02-15 |
| NCT02834663 |
Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02834663 |
Completed |
Wonkwang University Hospital |
2019-02-28 |
| NCT02826655 |
Adaptive Optics for Ophthalmic Technologies |
https://ClinicalTrials.gov/show/NCT02826655 |
Recruiting |
Duke University |
2021-06-30 |
| NCT02818998 |
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02818998 |
Completed |
Bayer |
2018-11-13 |
| NCT02796183 |
The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02796183 |
Completed |
Neon Hospital |
2016-04-30 |
| NCT02790775 |
Pain and Visual Outcome in Intravitreal Bevacizumab Injection |
https://ClinicalTrials.gov/show/NCT02790775 |
Completed |
Shahid Beheshti University of Medical Sciences |
2016-05-30 |
| NCT02788877 |
Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) |
https://ClinicalTrials.gov/show/NCT02788877 |
Active, not recruiting |
Pusan National University Hospital |
2019-09-30 |
| NCT02772497 |
3 Month Outcome of Ziv-aflibercept for DME |
https://ClinicalTrials.gov/show/NCT02772497 |
Completed |
Marashi Eye Clinic |
2016-05-31 |
| NCT02764697 |
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients |
https://ClinicalTrials.gov/show/NCT02764697 |
Completed |
Tampa Bay Uveitis Center, LLC |
2016-12-07 |
| NCT02734407 |
Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02734407 |
Completed |
Retina-Vitreous Associates Medical Group |
2017-09-27 |
| NCT02732951 |
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02732951 |
Completed |
Boehringer Ingelheim |
2017-10-23 |
| NCT02712008 |
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02712008 |
Completed |
Regeneron Pharmaceuticals |
2017-07-10 |
| NCT02699450 |
A Study of Faricimab (RO6867461) in Participants With Center-involving Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02699450 |
Completed |
Hoffmann-La Roche |
2017-09-15 |
| NCT02698566 |
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) |
https://ClinicalTrials.gov/show/NCT02698566 |
Completed |
Genentech, Inc. |
2016-04-05 |
| NCT02688309 |
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases |
https://ClinicalTrials.gov/show/NCT02688309 |
Recruiting |
Johns Hopkins University |
2021-07-31 |
| NCT02663141 |
Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02663141 |
Completed |
Tehran University of Medical Sciences |
2016-06-30 |
| NCT02646670 |
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02646670 |
Completed |
Instituto de Olhos de Goiania |
2015-10-31 |
| NCT02646072 |
Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients |
https://ClinicalTrials.gov/show/NCT02646072 |
Completed |
University of Malaya |
2015-05-31 |
| NCT02645266 |
Mean Visual Acuity Changes Following Five Injections of Aflibercept |
https://ClinicalTrials.gov/show/NCT02645266 |
Recruiting |
McMaster University |
2018-12-31 |
| NCT02634333 |
Anti-VEGF Treatment for Prevention of PDR/DME |
https://ClinicalTrials.gov/show/NCT02634333 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-05-31 |
| NCT02633852 |
Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02633852 |
Completed |
Hadassah Medical Organization |
2018-08-28 |
| NCT02623426 |
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial |
https://ClinicalTrials.gov/show/NCT02623426 |
Active, not recruiting |
JHSPH Center for Clinical Trials |
2021-01-31 |
| NCT02614937 |
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02614937 |
Completed |
Ohr Pharmaceutical Inc. |
2014-12-31 |
| NCT02609165 |
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT02609165 |
Completed |
Ospedale San Raffaele |
2017-02-28 |
| NCT02595398 |
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis |
https://ClinicalTrials.gov/show/NCT02595398 |
Completed |
Clearside Biomedical, Inc. |
2018-01-18 |
| NCT02800642 |
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO |
https://ClinicalTrials.gov/show/NCT02800642 |
Completed |
Bayer |
2019-07-31 |
| NCT02571972 |
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. |
https://ClinicalTrials.gov/show/NCT02571972 |
Completed |
Wills Eye |
2015-09-30 |
| NCT02559180 |
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab |
https://ClinicalTrials.gov/show/NCT02559180 |
Recruiting |
The Cleveland Clinic |
2020-11-30 |
| NCT02556723 |
Intravitreal Injections of Ziv-aflibercept for Macular Diseases |
https://ClinicalTrials.gov/show/NCT02556723 |
Completed |
Retina Clinic, Sao Paulo, Brazil |
2015-09-30 |
| NCT03397264 |
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03397264 |
Active, not recruiting |
Opthea Limited |
2020-05-31 |
| NCT02556424 |
Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema |
https://ClinicalTrials.gov/show/NCT02556424 |
Recruiting |
Nantes University Hospital |
2020-10-31 |
| NCT02554747 |
Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa |
https://ClinicalTrials.gov/show/NCT02554747 |
Completed |
Odense University Hospital |
2017-12-31 |
| NCT02530918 |
Study of DS-7080a for the Treatment of Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02530918 |
Completed |
Daiichi Sankyo, Inc. |
2018-01-02 |
| NCT02510885 |
SD-OCT Angiography |
https://ClinicalTrials.gov/show/NCT02510885 |
Recruiting |
Duke University |
2020-05-31 |
| NCT02503540 |
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO |
https://ClinicalTrials.gov/show/NCT02503540 |
Completed |
The Cleveland Clinic |
2018-02-06 |
| NCT02486484 |
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection |
https://ClinicalTrials.gov/show/NCT02486484 |
Recruiting |
Rafic Hariri University Hospital |
2019-05-31 |
| NCT02478515 |
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02478515 |
Completed |
Nagoya City University |
2019-03-31 |
| NCT02472366 |
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy |
https://ClinicalTrials.gov/show/NCT02472366 |
Completed |
Alimera Sciences |
2015-03-31 |
| NCT02471651 |
Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02471651 |
Completed |
California Retina Consultants |
2018-10-24 |
| NCT02457975 |
Photobiomodulation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02457975 |
Completed |
Medical College of Wisconsin |
2019-08-30 |
| NCT02457884 |
Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT02457884 |
Completed |
The Hong Kong Polytechnic University |
2018-03-31 |
| NCT02448446 |
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates |
https://ClinicalTrials.gov/show/NCT02448446 |
Completed |
South Coast Retina Center; Carson, McBeath, Boswell, Inc. |
2018-05-31 |
| NCT02443012 |
Topical Nepafenac as Supplement for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02443012 |
Completed |
Universiti Sains Malaysia |
2014-08-31 |
| NCT02441907 |
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02441907 |
Completed |
St. Michael’s Hospital, Toronto |
2018-08-31 |
| NCT02424019 |
Phase 4 IOP Signals Associated With ILUVIEN® |
https://ClinicalTrials.gov/show/NCT02424019 |
Active, not recruiting |
Alimera Sciences |
2019-12-31 |
| NCT02406157 |
577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02406157 |
Completed |
Sun Yat-sen University |
2018-07-31 |
| NCT02403128 |
Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms |
https://ClinicalTrials.gov/show/NCT02403128 |
Active, not recruiting |
Illinois Retina and Eye Associates |
2020-02-29 |
| NCT02392364 |
Variable Interval Versus Set Interval Aflibercept for DME |
https://ClinicalTrials.gov/show/NCT02392364 |
Completed |
California Retina Consultants |
2018-11-15 |
| NCT02363621 |
Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME |
https://ClinicalTrials.gov/show/NCT02363621 |
Completed |
Sierra Eye Associates |
2017-10-31 |
| NCT02359526 |
A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients |
https://ClinicalTrials.gov/show/NCT02359526 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2016-03-31 |
| NCT02348918 |
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02348918 |
Completed |
Allegro Ophthalmics, LLC |
2017-05-16 |
| NCT02314299 |
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02314299 |
Completed |
Stealth BioTherapeutics Inc. |
2015-05-31 |
| NCT02310295 |
Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02310295 |
Completed |
University of Sao Paulo |
2011-12-31 |
| NCT02308644 |
Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study |
https://ClinicalTrials.gov/show/NCT02308644 |
Completed |
University of Sao Paulo |
2011-12-31 |
| NCT02303184 |
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO |
https://ClinicalTrials.gov/show/NCT02303184 |
Completed |
Clearside Biomedical, Inc. |
2016-03-31 |
| NCT02302079 |
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02302079 |
Completed |
Astellas Pharma Inc |
2016-08-12 |
| NCT02299336 |
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial |
https://ClinicalTrials.gov/show/NCT02299336 |
Completed |
Greater Houston Retina Research |
2017-01-09 |
| NCT02297204 |
The Endurance 1 Trial |
https://ClinicalTrials.gov/show/NCT02297204 |
Completed |
Northern California Retina Vitreous Associates |
2017-12-13 |
| NCT02294656 |
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide |
https://ClinicalTrials.gov/show/NCT02294656 |
Completed |
Soll Eye |
2018-09-30 |
| NCT02262260 |
Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME |
https://ClinicalTrials.gov/show/NCT02262260 |
Completed |
Novartis |
2017-09-12 |
| NCT02259088 |
A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients |
https://ClinicalTrials.gov/show/NCT02259088 |
Completed |
Novartis |
2017-01-17 |
| NCT02255032 |
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis |
https://ClinicalTrials.gov/show/NCT02255032 |
Completed |
Clearside Biomedical, Inc. |
2015-12-31 |
| NCT02245516 |
Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02245516 |
Completed |
Kala Pharmaceuticals, Inc. |
2014-12-31 |
| NCT02221453 |
Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide |
https://ClinicalTrials.gov/show/NCT02221453 |
Completed |
St. Michael’s Hospital, Toronto |
2016-12-31 |
| NCT02207712 |
Noctura400 Treatment for Diabetic Retinopathy (CANDLE) |
https://ClinicalTrials.gov/show/NCT02207712 |
Active, not recruiting |
PolyPhotonix Medical |
2020-07-31 |
| NCT02193113 |
A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME |
https://ClinicalTrials.gov/show/NCT02193113 |
Completed |
KalVista Pharmaceuticals, Ltd. |
2015-06-04 |
| NCT02186119 |
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02186119 |
Completed |
Allergan |
2015-06-30 |
| NCT02181400 |
Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT02181400 |
Completed |
University of Sydney |
2019-02-15 |
| NCT02140411 |
Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. |
https://ClinicalTrials.gov/show/NCT02140411 |
Completed |
Novartis |
2016-12-21 |
| NCT02140164 |
Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02140164 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-11-30 |
| NCT02121262 |
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02121262 |
Completed |
Allergan |
2019-10-09 |
| NCT02118831 |
Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF |
https://ClinicalTrials.gov/show/NCT02118831 |
Completed |
California Retina Consultants |
2014-02-28 |
| NCT02107131 |
Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab |
https://ClinicalTrials.gov/show/NCT02107131 |
Completed |
California Retina Consultants |
2017-05-15 |
| NCT02103283 |
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02103283 |
Completed |
River Vision Development Corporation |
2016-08-31 |
| NCT02084576 |
Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification |
https://ClinicalTrials.gov/show/NCT02084576 |
Completed |
Hospital Oftalmologico de Brasilia |
2013-08-31 |
| NCT01315275 |
A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema |
https://ClinicalTrials.gov/show/NCT01315275 |
Completed |
Novartis |
2012-08-31 |
| NCT01309451 |
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01309451 |
Completed |
Maturi, Raj K., M.D., P.C. |
2013-04-30 |
| NCT01304706 |
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study |
https://ClinicalTrials.gov/show/NCT01304706 |
Completed |
Alimera Sciences |
2013-11-30 |
| NCT01298076 |
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01298076 |
Completed |
University of Sydney |
2014-09-30 |
| NCT01297569 |
Ranibizumab “Treat and Extend” in Diabetic Macular Edma |
https://ClinicalTrials.gov/show/NCT01297569 |
Completed |
Novartis |
2012-11-30 |
| NCT01292798 |
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab |
https://ClinicalTrials.gov/show/NCT01292798 |
Completed |
California Retina Consultants |
2013-04-30 |
| NCT01284478 |
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01284478 |
Completed |
Northern California Retina Vitreous Associates |
2012-10-31 |
| NCT01277302 |
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01277302 |
Completed |
Genentech, Inc. |
2012-10-31 |
| NCT01273727 |
Ozurdex for Macular Edema Post Membrane Peeling |
https://ClinicalTrials.gov/show/NCT01273727 |
Completed |
Retina Specialists, PC |
2014-04-30 |
| NCT02050828 |
The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02050828 |
Completed |
Aerpio Therapeutics |
2015-04-30 |
| NCT02036424 |
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02036424 |
Completed |
Maturi, Raj K., M.D., P.C. |
2015-08-31 |
| NCT03355638 |
Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 |
https://ClinicalTrials.gov/show/NCT03355638 |
Completed |
Università degli Studi di Brescia |
2016-07-31 |
| NCT02006147 |
Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO |
https://ClinicalTrials.gov/show/NCT02006147 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT02002403 |
Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02002403 |
Completed |
St. Michael’s Hospital, Toronto |
2012-04-30 |
| NCT01997164 |
Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (“Wet”) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01997164 |
Completed |
Regeneron Pharmaceuticals |
2015-10-31 |
| NCT01988246 |
Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01988246 |
Completed |
The Cleveland Clinic |
2018-04-25 |
| NCT01982435 |
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01982435 |
Completed |
The Cleveland Clinic |
2016-05-26 |
| NCT01976338 |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01976338 |
Completed |
Novartis |
2016-03-28 |
| NCT01975103 |
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases |
https://ClinicalTrials.gov/show/NCT01975103 |
Recruiting |
Federal University of Rio Grande do Sul |
2020-04-30 |
| NCT04418427 |
ADVM-022 Intravitreal Gene Therapy for DME |
https://ClinicalTrials.gov/show/NCT04418427 |
Recruiting |
Adverum Biotechnologies, Inc. |
2021-05-31 |
| NCT01939691 |
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial |
https://ClinicalTrials.gov/show/NCT01939691 |
Recruiting |
University of California, San Francisco |
2020-11-30 |
| NCT01934556 |
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01934556 |
Completed |
Palmetto Retina Center, LLC |
2017-04-30 |
| NCT01909791 |
Treatment for CI-DME in Eyes With Very Good VA Study |
https://ClinicalTrials.gov/show/NCT01909791 |
Completed |
Jaeb Center for Health Research |
2018-09-11 |
| NCT01903720 |
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01903720 |
Completed |
Allergan |
2014-09-24 |
| NCT01908816 |
An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. |
https://ClinicalTrials.gov/show/NCT01908816 |
Completed |
Novartis |
2016-01-08 |
| NCT01892163 |
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone |
https://ClinicalTrials.gov/show/NCT01892163 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-12-31 |
| NCT01875783 |
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits |
https://ClinicalTrials.gov/show/NCT01875783 |
Completed |
Joslin Diabetes Center |
2015-05-14 |
| NCT01870440 |
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema |
https://ClinicalTrials.gov/show/NCT01870440 |
Completed |
Northern California Retina Vitreous Associates |
2015-02-28 |
| NCT01870427 |
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions |
https://ClinicalTrials.gov/show/NCT01870427 |
Completed |
Northern California Retina Vitreous Associates |
2015-08-31 |
| NCT01846299 |
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema |
https://ClinicalTrials.gov/show/NCT01846299 |
Completed |
Novartis |
2015-09-30 |
| NCT01823965 |
Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment |
https://ClinicalTrials.gov/show/NCT01823965 |
Completed |
Poitiers University Hospital |
2014-07-31 |
| NCT01823081 |
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01823081 |
Completed |
Shahid Beheshti University of Medical Sciences |
2013-06-30 |
| NCT01821677 |
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01821677 |
Completed |
Ampio Pharmaceuticals. Inc. |
2014-06-30 |
| NCT01787669 |
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01787669 |
Completed |
University of Sydney |
2017-01-31 |
| NCT01783886 |
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement |
https://ClinicalTrials.gov/show/NCT01783886 |
Completed |
Bayer |
2015-03-31 |
| NCT01774474 |
PRevention of Macular EDema After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01774474 |
Completed |
Maastricht University Medical Center |
2016-11-04 |
| NCT01767545 |
Dexamethasone-implant for the Treatment of RVO |
https://ClinicalTrials.gov/show/NCT01767545 |
Completed |
Ludwig-Maximilians - University of Munich |
2011-01-31 |
| NCT01766362 |
Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients. |
https://ClinicalTrials.gov/show/NCT01766362 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-11-30 |
| NCT01748487 |
The Effect of Intravitreal Ozurdex on DME After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01748487 |
Completed |
University Health Network, Toronto |
2015-09-30 |
| NCT01732614 |
Topcon Endpoint Management |
https://ClinicalTrials.gov/show/NCT01732614 |
Completed |
Retinal Consultants of Arizona |
2013-11-30 |
| NCT01702441 |
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01702441 |
Completed |
Aerpio Therapeutics |
2013-09-30 |
| NCT01698788 |
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698788 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-12-31 |
| NCT01698749 |
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698749 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-01-31 |
| NCT01694212 |
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01694212 |
Completed |
Eye Clinic Medic Zuljan Jukic |
2016-10-31 |
| NCT01673191 |
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01673191 |
Completed |
Retinal Consultants of Arizona |
2014-12-31 |
| NCT01662518 |
DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01662518 |
Completed |
Centro de Pesquisa Rubens Siqueira |
2016-01-31 |
| NCT01661946 |
Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye |
https://ClinicalTrials.gov/show/NCT01661946 |
Completed |
Queen’s University |
2013-07-31 |
| NCT01660802 |
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01660802 |
Completed |
Allergan |
2014-03-31 |
| NCT01640171 |
Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival |
https://ClinicalTrials.gov/show/NCT01640171 |
Completed |
Retina Vitreous Associates of Florida |
2013-09-30 |
| NCT01638858 |
Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) |
https://ClinicalTrials.gov/show/NCT01638858 |
Completed |
University of Luebeck |
2014-07-31 |
| NCT01627249 |
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01627249 |
Completed |
Jaeb Center for Health Research |
2014-10-31 |
| NCT01613716 |
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) |
https://ClinicalTrials.gov/show/NCT01613716 |
Completed |
The Cleveland Clinic |
2016-12-31 |
| NCT01610557 |
Ranibizumab and Bevacizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01610557 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-02-28 |
| NCT01579760 |
Intravitreal Aflibercept Injection for Radiation Retinopathy |
https://ClinicalTrials.gov/show/NCT01579760 |
Completed |
Washington University School of Medicine |
2019-01-31 |
| NCT01571232 |
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01571232 |
Completed |
Retina Macula Institute |
2014-02-28 |
| NCT01564108 |
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema |
https://ClinicalTrials.gov/show/NCT01564108 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-06-30 |
| NCT01552408 |
Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) |
https://ClinicalTrials.gov/show/NCT01552408 |
Completed |
Greater Houston Retina Research |
2017-05-18 |
| NCT01546402 |
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01546402 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-11-30 |
| NCT01542190 |
Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01542190 |
Completed |
University of Campinas, Brazil |
2012-12-31 |
| NCT01535261 |
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01535261 |
Completed |
Novartis |
2015-03-31 |
| NCT01512901 |
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) |
https://ClinicalTrials.gov/show/NCT01512901 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01506895 |
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01506895 |
Completed |
GlaxoSmithKline |
2013-02-28 |
| NCT01492400 |
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01492400 |
Completed |
Allergan |
2014-02-13 |
| NCT01476449 |
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema |
https://ClinicalTrials.gov/show/NCT01476449 |
Completed |
Retina Vitreous Associates of Florida |
2016-09-30 |
| NCT01473251 |
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01473251 |
Completed |
Vitreo-Retinal Associates, Michigan |
2014-04-30 |
| NCT01472510 |
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy |
https://ClinicalTrials.gov/show/NCT01472510 |
Completed |
Vitreo-Retinal Associates, PC |
2013-07-31 |
| NCT01471691 |
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab |
https://ClinicalTrials.gov/show/NCT01471691 |
Completed |
Hanscom, Thomas, M.D. |
2014-02-28 |
| NCT01449682 |
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. |
https://ClinicalTrials.gov/show/NCT01449682 |
Completed |
Retina Macula Institute |
2012-07-31 |
| NCT01445899 |
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01445899 |
Completed |
Quark Pharmaceuticals |
2013-11-30 |
| NCT01442064 |
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) |
https://ClinicalTrials.gov/show/NCT01442064 |
Completed |
Genentech, Inc. |
2010-07-31 |
| NCT01441102 |
Dextromethorphan for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01441102 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-06-30 |
| NCT01428388 |
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01428388 |
Completed |
Barnes Retina Institute |
2015-10-31 |
| NCT01427751 |
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01427751 |
Completed |
Allergan |
2014-11-04 |
| NCT01411254 |
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) |
https://ClinicalTrials.gov/show/NCT01411254 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01396083 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01396083 |
Completed |
Novartis |
2014-01-31 |
| NCT01396057 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01396057 |
Completed |
Novartis |
2013-06-30 |
| NCT01395069 |
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01395069 |
Completed |
Queen’s University |
2011-05-31 |
| NCT01385852 |
CME With Different Fluidic Parameters |
https://ClinicalTrials.gov/show/NCT01385852 |
Completed |
Iladevi Cataract and IOL Research Center |
2011-02-28 |
| NCT01376362 |
Topical Interferon Gamma for Macular Edema Secondary to Uveitis |
https://ClinicalTrials.gov/show/NCT01376362 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-02-29 |
| NCT01363440 |
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01363440 |
Completed |
Regeneron Pharmaceuticals |
2013-01-31 |
| NCT01355692 |
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01355692 |
Completed |
Lumenis Ltd. |
2015-06-30 |
| NCT01342159 |
Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01342159 |
Completed |
Hallym University Medical Center |
2010-02-28 |
| NCT01331681 |
Intravitreal Aflibercept Injection in Vision Impairment Due to DME |
https://ClinicalTrials.gov/show/NCT01331681 |
Completed |
Bayer |
2013-06-30 |
| NCT01331005 |
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01331005 |
Completed |
Jaeb Center for Health Research |
2013-12-31 |
| NCT01324869 |
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01324869 |
Completed |
Chengdu Kanghong Biotech Co., Ltd. |
2012-02-29 |
| NCT01319487 |
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01319487 |
Completed |
Fovea Pharmaceuticals SA |
2012-03-31 |
| NCT04411693 |
Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04411693 |
Recruiting |
The Cleveland Clinic |
2021-06-01 |
| NCT04359771 |
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04359771 |
Completed |
Cairo University |
2018-09-25 |
| NCT04332133 |
Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04332133 |
Completed |
Minia University |
2019-03-31 |
| NCT04290195 |
Use of Ziv Aflibercept in Different Retinal Diseases |
https://ClinicalTrials.gov/show/NCT04290195 |
Completed |
Tanta University |
2019-12-01 |
| NCT04288232 |
Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan |
https://ClinicalTrials.gov/show/NCT04288232 |
Completed |
Taipei Veterans General Hospital, Taiwan |
2017-11-16 |
| NCT04234438 |
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser |
https://ClinicalTrials.gov/show/NCT04234438 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT04187443 |
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema |
https://ClinicalTrials.gov/show/NCT04187443 |
Recruiting |
MingSight Pharmaceuticals Pty Limited |
2021-08-18 |
| NCT04186702 |
New Concepts in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT04186702 |
Completed |
Ain Shams University |
2016-10-01 |
| NCT04151407 |
The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT04151407 |
Recruiting |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2020-12-31 |
| NCT04142164 |
Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections |
https://ClinicalTrials.gov/show/NCT04142164 |
Recruiting |
Vienna Institute for Research in Ocular Surgery |
2021-01-01 |
| NCT04129021 |
Multimodal Ophthalmic Imaging |
https://ClinicalTrials.gov/show/NCT04129021 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2023-06-30 |
| NCT04120636 |
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120636 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-10-30 |
| NCT04120311 |
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120311 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-08-25 |
| NCT04119921 |
Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab |
https://ClinicalTrials.gov/show/NCT04119921 |
Active, not recruiting |
Shahid Beheshti University of Medical Sciences |
2018-06-01 |
| NCT04108156 |
This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab |
https://ClinicalTrials.gov/show/NCT04108156 |
Recruiting |
Hoffmann-La Roche |
2021-10-31 |
| NCT04089605 |
Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04089605 |
Completed |
Far Eastern Memorial Hospital |
2018-11-01 |
| NCT04087746 |
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT04087746 |
Completed |
Minia University |
2019-01-31 |
| NCT04085341 |
A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT04085341 |
Active, not recruiting |
Graybug Vision |
2020-04-30 |
| NCT04069780 |
Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04069780 |
Recruiting |
Ain Shams University |
2020-08-07 |
| NCT04063358 |
Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT04063358 |
Recruiting |
Second Military Medical University |
2021-08-31 |
| NCT04038125 |
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME |
https://ClinicalTrials.gov/show/NCT04038125 |
Recruiting |
Retina Macula Specialists of Miami, LLC |
2020-08-31 |
| NCT04018482 |
Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) |
https://ClinicalTrials.gov/show/NCT04018482 |
Completed |
California Retina Consultants |
2019-08-14 |
| NCT04014556 |
Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04014556 |
Completed |
University of Alexandria |
2018-10-01 |
| NCT04005430 |
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema |
https://ClinicalTrials.gov/show/NCT04005430 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-06-15 |
| NCT03984110 |
The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial) |
https://ClinicalTrials.gov/show/NCT03984110 |
Recruiting |
Texas Retina Associates |
2020-06-15 |
| NCT03975088 |
Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03975088 |
Completed |
University of Alexandria |
2017-12-31 |
| NCT03974425 |
One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab |
https://ClinicalTrials.gov/show/NCT03974425 |
Completed |
University of Alexandria |
2017-04-01 |
| NCT03973138 |
Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab |
https://ClinicalTrials.gov/show/NCT03973138 |
Recruiting |
Sun Yat-sen University |
2020-01-01 |
| NCT03956797 |
Long Term Safety of Cooling Anesthesia for Intravitreal Injection |
https://ClinicalTrials.gov/show/NCT03956797 |
Recruiting |
Recens Medical, Inc. |
2020-05-30 |
| NCT03953807 |
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated |
https://ClinicalTrials.gov/show/NCT03953807 |
Recruiting |
Allergan |
2021-05-31 |
| NCT03918590 |
Post Intravitreal Injection Topical NSAID vs. Patching |
https://ClinicalTrials.gov/show/NCT03918590 |
Enrolling by invitation |
The New York Eye & Ear Infirmary |
2019-05-01 |
| NCT03917472 |
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03917472 |
Active, not recruiting |
Novartis |
2021-07-30 |
| NCT03908723 |
Treatment of Macular Edema Caused by Leber’s Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT03908723 |
Recruiting |
Alexandria University |
2021-03-29 |
| NCT03908307 |
Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China |
https://ClinicalTrials.gov/show/NCT03908307 |
Recruiting |
Allergan |
2021-09-30 |
| NCT03892434 |
Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO |
https://ClinicalTrials.gov/show/NCT03892434 |
Recruiting |
Yeungnam University College of Medicine |
2019-12-18 |
| NCT03866746 |
Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866746 |
Completed |
Al Hadi Hospital |
2017-06-21 |
| NCT03866473 |
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866473 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-04-21 |
| NCT03835884 |
A Study Assessing AR-13503 Implant Alone and in Combination With Aflibercept in Subjects With nAMD or DME |
https://ClinicalTrials.gov/show/NCT03835884 |
Active, not recruiting |
Aerie Pharmaceuticals |
2021-09-30 |
| NCT03832179 |
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification |
https://ClinicalTrials.gov/show/NCT03832179 |
Recruiting |
Bay Area Retina Associates |
2020-06-01 |
| NCT03802630 |
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03802630 |
Recruiting |
Novartis |
2023-05-26 |
| NCT03759860 |
Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03759860 |
Active, not recruiting |
LUTRONIC Corporation |
2019-07-30 |
| NCT03739593 |
Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03739593 |
Active, not recruiting |
Aerie Pharmaceuticals |
2020-05-31 |
| NCT03732287 |
Cooling Anesthesia for Intravitreal Injection |
https://ClinicalTrials.gov/show/NCT03732287 |
Completed |
Recens Medical, Inc. |
2019-04-26 |
| NCT03690947 |
Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME |
https://ClinicalTrials.gov/show/NCT03690947 |
Recruiting |
Beijing Hospital |
2020-09-30 |
| NCT03690050 |
A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. |
https://ClinicalTrials.gov/show/NCT03690050 |
Recruiting |
Belfast Health and Social Care Trust |
2020-12-31 |
| NCT03666923 |
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03666923 |
Completed |
Oxurion |
2019-11-20 |
| NCT03660371 |
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging |
https://ClinicalTrials.gov/show/NCT03660371 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03660345 |
Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03660345 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03651011 |
Navigated Laser In Branch Retinal Vein Occlusion Study |
https://ClinicalTrials.gov/show/NCT03651011 |
Recruiting |
Odense University Hospital |
2020-08-10 |
| NCT03641144 |
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03641144 |
Recruiting |
Sun Yat-sen University |
2019-07-31 |
| NCT03635814 |
The Study to YD312 Tablet in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03635814 |
Active, not recruiting |
YD Global Life Science Co., Ltd. |
2018-07-27 |
| NCT03622593 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03622593 |
Enrolling by invitation |
Hoffmann-La Roche |
2020-09-30 |
| NCT03622580 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) |
https://ClinicalTrials.gov/show/NCT03622580 |
Active, not recruiting |
Hoffmann-La Roche |
2020-09-30 |
| NCT03608839 |
Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT03608839 |
Completed |
Universidade Federal de Pernambuco |
2017-12-20 |
| NCT03606733 |
Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders |
https://ClinicalTrials.gov/show/NCT03606733 |
Recruiting |
Marashi Eye Clinic |
2019-08-01 |
| NCT03598205 |
Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03598205 |
Completed |
Fondazione G.B. Bietti, IRCCS |
2018-09-28 |
| NCT03590444 |
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser |
https://ClinicalTrials.gov/show/NCT03590444 |
Completed |
Hospital Hietzing |
2018-04-02 |
| NCT03533478 |
Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema |
https://ClinicalTrials.gov/show/NCT03533478 |
Completed |
Catalysis SL |
2018-12-01 |
| NCT03519581 |
Micropulse for Suppression of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03519581 |
Recruiting |
University of California, Davis |
2020-12-31 |
| NCT03511898 |
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03511898 |
Completed |
Oxurion |
2019-05-22 |
| NCT03499223 |
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03499223 |
Completed |
Oxurion |
2019-07-18 |
| NCT03495765 |
To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT03495765 |
Completed |
Marsden Eye Specialists |
2017-01-01 |
| NCT03481660 |
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481660 |
Active, not recruiting |
Novartis |
2020-07-15 |
| NCT03481634 |
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481634 |
Active, not recruiting |
Novartis |
2020-11-11 |
| NCT03466099 |
Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) |
https://ClinicalTrials.gov/show/NCT03466099 |
Completed |
KalVista Pharmaceuticals, Ltd. |
2019-10-10 |
| NCT03465124 |
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery |
https://ClinicalTrials.gov/show/NCT03465124 |
Active, not recruiting |
Medical University of Vienna |
2019-02-19 |
| NCT03453281 |
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection |
https://ClinicalTrials.gov/show/NCT03453281 |
Completed |
Indonesia University |
2018-04-09 |
| NCT01259609 |
Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy |
https://ClinicalTrials.gov/show/NCT01259609 |
Completed |
Seoul National University Hospital |
2010-04-30 |
| NCT01257815 |
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment |
https://ClinicalTrials.gov/show/NCT01257815 |
Completed |
Novartis |
2013-04-30 |
| NCT01247220 |
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study |
https://ClinicalTrials.gov/show/NCT01247220 |
Completed |
Retina Associates of Florida, P.A. |
2014-05-31 |
| NCT01231633 |
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01231633 |
Completed |
Long Island Vitreoretinal Consultants |
2014-09-30 |
| NCT01219205 |
Major and Macular Branched Retinal Venous Occlusion |
https://ClinicalTrials.gov/show/NCT01219205 |
Completed |
Hallym University Medical Center |
2009-02-28 |
| NCT01208948 |
Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01208948 |
Completed |
Ludwig-Maximilians - University of Munich |
2005-04-30 |
| NCT01202461 |
Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01202461 |
Completed |
Samsung Medical Center |
2010-08-31 |
| NCT01198327 |
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01198327 |
Completed |
Johns Hopkins University |
2012-12-31 |
| NCT01189461 |
Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01189461 |
Completed |
Pfizer |
2012-07-31 |
| NCT01175070 |
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01175070 |
Completed |
University of Oxford |
2013-03-31 |
| NCT01171976 |
Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01171976 |
Completed |
Novartis |
2013-04-30 |
| NCT01135914 |
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01135914 |
Completed |
Novartis |
2013-03-31 |
| NCT01120899 |
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01120899 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-08-31 |
| NCT01112085 |
MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) |
https://ClinicalTrials.gov/show/NCT01112085 |
Completed |
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion |
2014-01-31 |
| NCT01100307 |
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01100307 |
Completed |
Pfizer |
2012-08-31 |
| NCT01085734 |
Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01085734 |
Completed |
Maturi, Raj K., M.D., P.C. |
2011-10-31 |
| NCT01077401 |
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study |
https://ClinicalTrials.gov/show/NCT01077401 |
Completed |
Johns Hopkins University |
2012-03-31 |
| NCT01030601 |
Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) |
https://ClinicalTrials.gov/show/NCT01030601 |
Completed |
University Health Network, Toronto |
2011-01-31 |
| NCT01028248 |
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01028248 |
Completed |
California Retina Consultants |
2012-06-30 |
| NCT01027650 |
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01027650 |
Completed |
Allergan |
2012-04-30 |
| NCT00997191 |
Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) |
https://ClinicalTrials.gov/show/NCT00997191 |
Completed |
University of Sao Paulo |
2011-11-30 |
| NCT00994955 |
Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00994955 |
Completed |
University of Schleswig-Holstein |
2008-12-31 |
| NCT00989989 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00989989 |
Completed |
Novartis |
2011-08-31 |
| NCT00974753 |
Prophylactic Ketorolac Post Epiretinal Membrane Surgery |
https://ClinicalTrials.gov/show/NCT00974753 |
Completed |
Queen’s University |
2012-03-31 |
| NCT00970957 |
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00970957 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2013-02-28 |
| NCT00970723 |
High Blood Pressure and Sleep Apnea in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00970723 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-01-31 |
| NCT00943982 |
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma |
https://ClinicalTrials.gov/show/NCT00943982 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-06-24 |
| NCT00943072 |
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00943072 |
Completed |
Regeneron Pharmaceuticals |
2010-10-31 |
| NCT00942864 |
Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT00942864 |
Completed |
Novartis |
2009-12-31 |
| NCT00915837 |
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00915837 |
Completed |
SurModics, Inc. |
2009-04-30 |
| NCT00907114 |
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00907114 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00901186 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00901186 |
Completed |
Novartis |
2012-08-31 |
| NCT00900887 |
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema |
https://ClinicalTrials.gov/show/NCT00900887 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00886808 |
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00886808 |
Completed |
iCo Therapeutics Inc. |
2010-05-31 |
| NCT00874744 |
Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00874744 |
Completed |
Universidade Federal de Goias |
2008-09-30 |
| NCT00846092 |
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00846092 |
Completed |
Medical College of Wisconsin |
2013-02-28 |
| NCT04296838 |
Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF |
https://ClinicalTrials.gov/show/NCT04296838 |
Recruiting |
Peking Union Medical College Hospital |
2020-05-31 |
| NCT03821168 |
The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03821168 |
Recruiting |
Shahid Beheshti University of Medical Sciences |
2019-04-01 |
| NCT00826618 |
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00826618 |
Completed |
University of Miami |
2012-09-30 |
| NCT04448496 |
Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema |
https://ClinicalTrials.gov/show/NCT04448496 |
Recruiting |
Yeungnam University College of Medicine |
2021-12-31 |
| NCT03927690 |
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03927690 |
Recruiting |
Novartis |
2021-02-09 |
| NCT01769352 |
Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1) |
https://ClinicalTrials.gov/show/NCT01769352 |
Completed |
Johns Hopkins University |
2016-04-30 |
| NCT00815360 |
Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion |
https://ClinicalTrials.gov/show/NCT00815360 |
Completed |
Retina Associates of Florida, P.A. |
2011-07-31 |
| NCT01978015 |
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG |
https://ClinicalTrials.gov/show/NCT01978015 |
Completed |
University of Campinas, Brazil |
2012-07-31 |
| NCT01945866 |
Phase II Combination Steroid and Anti-VEGF for Persistent DME |
https://ClinicalTrials.gov/show/NCT01945866 |
Completed |
Jaeb Center for Health Research |
2017-06-05 |
| NCT01512966 |
Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) |
https://ClinicalTrials.gov/show/NCT01512966 |
Completed |
Bayer |
2013-09-30 |
| NCT01486238 |
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study |
https://ClinicalTrials.gov/show/NCT01486238 |
Completed |
Valley Retina Institute |
2011-07-31 |
| NCT00806169 |
Combined Triple Therapy in Diabetic Retinopathy (DRP) |
https://ClinicalTrials.gov/show/NCT00806169 |
Completed |
Johann Wolfgang Goethe University Hospital |
2008-10-31 |
| NCT00804921 |
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab |
https://ClinicalTrials.gov/show/NCT00804921 |
Completed |
University of Sao Paulo |
NA |
| NCT00801866 |
Avastin for Post-Photocoagulation Macular Edema |
https://ClinicalTrials.gov/show/NCT00801866 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT02581995 |
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. |
https://ClinicalTrials.gov/show/NCT02581995 |
Completed |
Bayer |
2017-08-09 |
| NCT03866005 |
Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866005 |
Recruiting |
ZeaVision, LLC |
2021-11-01 |
| NCT03790852 |
Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO |
https://ClinicalTrials.gov/show/NCT03790852 |
Active, not recruiting |
Kodiak Sciences Inc |
2021-06-30 |
| NCT02374060 |
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial |
https://ClinicalTrials.gov/show/NCT02374060 |
Completed |
JHSPH Center for Clinical Trials |
2017-08-30 |
| NCT01951066 |
Diabetic Macular Edema Treated With Ozurdex (DMEO) |
https://ClinicalTrials.gov/show/NCT01951066 |
Completed |
Johns Hopkins University |
2015-12-31 |
| NCT01573572 |
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium |
https://ClinicalTrials.gov/show/NCT01573572 |
Completed |
Bausch Health Americas, Inc. |
2019-11-04 |
| NCT03610646 |
Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03610646 |
Recruiting |
Mylan Inc. |
2020-02-28 |
| NCT00790803 |
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00790803 |
Completed |
Wake Forest University Health Sciences |
2011-11-30 |
| NCT00789477 |
DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact |
https://ClinicalTrials.gov/show/NCT00789477 |
Completed |
Regeneron Pharmaceuticals |
2009-12-31 |
| NCT00782717 |
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients |
https://ClinicalTrials.gov/show/NCT00782717 |
Completed |
Alcon Research |
2010-07-31 |
| NCT00780780 |
Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00780780 |
Completed |
Federal University of São Paulo |
2008-08-31 |
| NCT00764244 |
Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00764244 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-12-31 |
| NCT00758628 |
Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. |
https://ClinicalTrials.gov/show/NCT00758628 |
Completed |
Bp Consulting, Inc |
2009-05-31 |
| NCT00737971 |
Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00737971 |
Completed |
Federal University of São Paulo |
2012-12-31 |
| NCT00729846 |
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) |
https://ClinicalTrials.gov/show/NCT00729846 |
Completed |
California Retina Consultants |
2008-08-31 |
| NCT00711490 |
Sirolimus to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00711490 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-01-31 |
| NCT00687804 |
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study |
https://ClinicalTrials.gov/show/NCT00687804 |
Completed |
Novartis |
2010-01-31 |
| NCT00687154 |
Observational Study of DME Following Scatter Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00687154 |
Completed |
Jaeb Center for Health Research |
2008-01-31 |
| NCT00683176 |
Effect of Choline Fenofibrate (SLV348) on Macular Edema |
https://ClinicalTrials.gov/show/NCT00683176 |
Completed |
Abbott |
2011-03-31 |
| NCT00682539 |
Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00682539 |
Completed |
Medical University of Vienna |
2014-07-31 |
| NCT00682240 |
Morphological and Functional Retinal Changes Following Retinal Photocoagulation |
https://ClinicalTrials.gov/show/NCT00682240 |
Completed |
Medical University of Vienna |
2014-02-28 |
| NCT00668239 |
Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser |
https://ClinicalTrials.gov/show/NCT00668239 |
Completed |
Hospital de Clinicas de Porto Alegre |
2006-04-30 |
| NCT00665106 |
Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00665106 |
Completed |
Santen SAS |
2011-09-30 |
| NCT00656643 |
Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00656643 |
Completed |
Santen Inc. |
2009-11-30 |
| NCT00612261 |
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00612261 |
Completed |
Yonsei University |
2007-08-31 |
| NCT00605280 |
A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. |
https://ClinicalTrials.gov/show/NCT00605280 |
Completed |
Pfizer |
2009-11-30 |
| NCT00595543 |
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% |
https://ClinicalTrials.gov/show/NCT00595543 |
Completed |
Bp Consulting, Inc |
2009-03-31 |
| NCT00576459 |
Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00576459 |
Completed |
Bausch & Lomb Incorporated |
2006-06-30 |
| NCT00571831 |
The Effect of a Blue Light Filtering IOL |
https://ClinicalTrials.gov/show/NCT00571831 |
Completed |
Showa University |
NA |
| NCT00567697 |
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO |
https://ClinicalTrials.gov/show/NCT00567697 |
Completed |
Aleris Helse |
2008-10-31 |
| NCT00536692 |
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT00536692 |
Completed |
CoMentis |
NA |
| NCT00508040 |
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a |
https://ClinicalTrials.gov/show/NCT00508040 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-10-31 |
| NCT00502541 |
Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00502541 |
Completed |
Bausch & Lomb Incorporated |
2006-09-30 |
| NCT00498355 |
Lucentis for Inflammatory Macular Edema Trial |
https://ClinicalTrials.gov/show/NCT00498355 |
Completed |
University of California, San Francisco |
2009-01-31 |
| NCT00496405 |
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00496405 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00494494 |
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery |
https://ClinicalTrials.gov/show/NCT00494494 |
Completed |
University of North Carolina, Chapel Hill |
2008-04-30 |
| NCT00490815 |
Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00490815 |
Completed |
Alimera Sciences |
2009-09-30 |
| NCT00486018 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) |
https://ClinicalTrials.gov/show/NCT00486018 |
Completed |
Genentech, Inc. |
2009-05-31 |
| NCT00485836 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) |
https://ClinicalTrials.gov/show/NCT00485836 |
Completed |
Genentech, Inc. |
2009-06-30 |
| NCT00476593 |
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications |
https://ClinicalTrials.gov/show/NCT00476593 |
Completed |
Norwegian University of Science and Technology |
2009-12-31 |
| NCT00473382 |
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) |
https://ClinicalTrials.gov/show/NCT00473382 |
Completed |
Genentech, Inc. |
2011-01-31 |
| NCT00473330 |
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) |
https://ClinicalTrials.gov/show/NCT00473330 |
Completed |
Genentech, Inc. |
2010-11-30 |
| NCT00469781 |
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening |
https://ClinicalTrials.gov/show/NCT00469781 |
Completed |
Center For Excellence In Eye Care |
2008-09-30 |
| NCT00464685 |
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00464685 |
Completed |
Allergan |
2010-02-08 |
| NCT00446381 |
Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) |
https://ClinicalTrials.gov/show/NCT00446381 |
Completed |
Lawson Health Research Institute |
2008-09-30 |
| NCT00445003 |
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00445003 |
Completed |
Jaeb Center for Health Research |
2009-10-31 |
| NCT00444600 |
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00444600 |
Completed |
Jaeb Center for Health Research |
2009-12-31 |
| NCT00441662 |
Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema |
https://ClinicalTrials.gov/show/NCT00441662 |
Completed |
Wills Eye |
NA |
| NCT00440609 |
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00440609 |
Completed |
Long Island Vitreoretinal Consultants |
2012-11-30 |
| NCT00412451 |
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT00412451 |
Completed |
ThromboGenics |
2010-01-31 |
| NCT00411970 |
20- Versus 23- Gauge System for Pars Plana Vitrectomy |
https://ClinicalTrials.gov/show/NCT00411970 |
Completed |
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
NA |
| NCT00407355 |
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions |
https://ClinicalTrials.gov/show/NCT00407355 |
Completed |
Johns Hopkins University |
2013-02-28 |
| NCT00406107 |
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00406107 |
Completed |
Palmetto Retina Center, LLC |
2007-12-31 |
| NCT00403039 |
Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema |
https://ClinicalTrials.gov/show/NCT00403039 |
Completed |
Vitreous -Retina- Macula Consultants of New York |
2011-12-31 |
| NCT00401115 |
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00401115 |
Completed |
Santen Inc. |
2008-06-30 |
| NCT00387582 |
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00387582 |
Completed |
Rocky Mountain Retina Consultants |
2009-02-28 |
| NCT00379795 |
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO |
https://ClinicalTrials.gov/show/NCT00379795 |
Completed |
Genentech, Inc. |
2008-09-30 |
| NCT00371410 |
Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00371410 |
Completed |
Samsung Medical Center |
NA |
| NCT00369863 |
A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00369863 |
Completed |
Shahid Beheshti University of Medical Sciences |
NA |
| NCT00369486 |
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00369486 |
Completed |
Jaeb Center for Health Research |
2006-06-30 |
| NCT00367133 |
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00367133 |
Completed |
Jaeb Center for Health Research |
2008-05-31 |
| NCT00344968 |
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00344968 |
Completed |
Alimera Sciences |
2009-12-31 |
| NCT00344253 |
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis |
https://ClinicalTrials.gov/show/NCT00344253 |
Completed |
Heidelberg University |
2011-03-31 |
| NCT00336323 |
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) |
https://ClinicalTrials.gov/show/NCT00336323 |
Completed |
Jaeb Center for Health Research |
2006-11-30 |
| NCT00335439 |
Effect of Prophylactic Ketorolac on CME After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT00335439 |
Completed |
Queen’s University |
2007-05-31 |
| NCT00333671 |
Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) |
https://ClinicalTrials.gov/show/NCT00333671 |
Completed |
Glostrup University Hospital, Copenhagen |
2006-02-28 |
| NCT00320814 |
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00320814 |
Completed |
Regeneron Pharmaceuticals |
2006-08-31 |
| NCT00799227 |
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00799227 |
Completed |
Allergan |
2009-12-01 |
| NCT00308542 |
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00308542 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
NA |
| NCT00308477 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00308477 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
NA |
| NCT00306904 |
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00306904 |
Completed |
OPKO Health, Inc. |
2007-09-30 |
| NCT00284050 |
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement |
https://ClinicalTrials.gov/show/NCT00284050 |
Completed |
Novartis |
2008-06-30 |
| NCT00280826 |
Efalizumab to Treat Uveitis |
https://ClinicalTrials.gov/show/NCT00280826 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-02-28 |
| NCT00231023 |
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00231023 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00229931 |
Triamcinolone vs. Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00229931 |
Completed |
University of Oklahoma |
2013-05-31 |
| NCT00168389 |
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00168389 |
Completed |
Allergan |
2012-06-30 |
| NCT00168337 |
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00168337 |
Completed |
Allergan |
2012-05-31 |
| NCT00168324 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168324 |
Completed |
Allergan |
2008-03-01 |
| NCT00168298 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168298 |
Completed |
Allergan |
2008-03-01 |
| NCT00167518 |
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) |
https://ClinicalTrials.gov/show/NCT00167518 |
Completed |
University of Sydney |
NA |
| NCT00148330 |
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study |
https://ClinicalTrials.gov/show/NCT00148330 |
Completed |
University of Sydney |
2008-07-31 |
| NCT00148265 |
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT00148265 |
Completed |
University of Sydney |
2009-05-31 |
| NCT00133952 |
Effect of Ruboxistaurin on Clinically Significant Macular Edema |
https://ClinicalTrials.gov/show/NCT00133952 |
Completed |
Chromaderm, Inc. |
2011-07-31 |
| NCT00106132 |
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage |
https://ClinicalTrials.gov/show/NCT00106132 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00105404 |
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00105404 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00105027 |
The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study |
https://ClinicalTrials.gov/show/NCT00105027 |
Completed |
The Emmes Company, LLC |
2009-02-28 |
| NCT00101764 |
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders |
https://ClinicalTrials.gov/show/NCT00101764 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00090519 |
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00090519 |
Completed |
Chromaderm, Inc. |
2010-04-30 |
| NCT00088283 |
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00088283 |
Completed |
Eyetech Pharmaceuticals |
NA |
| NCT00071773 |
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00071773 |
Completed |
Jaeb Center for Health Research |
2005-11-30 |
| NCT00069056 |
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00069056 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00050479 |
Laser and Medical Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00050479 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00040313 |
Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula |
https://ClinicalTrials.gov/show/NCT00040313 |
Completed |
Eyetech Pharmaceuticals |
NA |
| NCT00035906 |
Research Study in Patients With Persistent Macular Edema |
https://ClinicalTrials.gov/show/NCT00035906 |
Completed |
Allergan |
2004-08-31 |
| NCT00027287 |
Laser and Medical Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00027287 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00545870 |
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00545870 |
Completed |
Medical University of Vienna |
2013-03-31 |
| NCT00021645 |
Vitamin E to Treat Uveitis-Associated Macular Edema |
https://ClinicalTrials.gov/show/NCT00021645 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00407381 |
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study |
https://ClinicalTrials.gov/show/NCT00407381 |
Completed |
Johns Hopkins University |
2010-08-31 |
| NCT00562406 |
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) |
https://ClinicalTrials.gov/show/NCT00562406 |
Completed |
Klinikum Ludwigshafen |
2010-09-30 |
| NCT00055042 |
Laser and Antioxidant Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00055042 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000115 |
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00000115 |
Completed |
National Eye Institute (NEI) |
NA |